Condition: Ventilator-associated Pneumonia · Sponsor: University Hospital, Toulouse
The main objective of this study is to compare the median exposures at pharmacokinetic equilibrium of the two modalities of administration: 4-hours infusion of ceftolozane-tazobactam at a dosage of 2 gram three times a day vs 1-hour infusion of 2 gram three times a day.
This description comes directly from the study's public registry record.
Stéphanie RUIZ, MD · 0561777032 · ruiz.s@chu-toulouse.fr
Nathalie ROQUES · roques.n@chu-toulouse.fr
Always discuss trial participation with your own doctor first.
| Service Réanimation Polyvalente - CHU Rangueil | Toulouse, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03581370